About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
Mar 09, 2020...
Electrons spin. It's a fundamental part of their existence. Some spin “up” while others spin “down.” Scientists have known this for about a century, thanks to quantum physics.
They've also known that magnetic fields can affect the direction of an electron’s quantum spin, flipping it from up to down and vice versa. And it doesn't take much: Even a bacterial cell can do it.
Researchers at USC Dornsife College of Letters, Arts and Sciences and Israel's Weizmann Institute of Science have found that protein “wires” connecting a bacterial cell to a solid surface tend to transmit electrons with a particular spin.
Oct 07, 2019...
Transplanting vaginal fluids from one woman to another could help tackle severe cases of a common bacterial condition, a study has suggested.
Bacterial vaginosis (BV) is thought to affect up to a third of women of reproductive age. It is caused when the balance of microbes in the vagina – known as the vaginal microbiome – becomes disturbed, with a drop in lactobacilli while other bacteria take over.
Mar 04, 2019...
Lymphoid organs in the small intestines. Red: B cells aggregated in the “training centers.” Green: cells with the ability to secrete effective antibodies exiting the centers for the intestinal tissue
REHOVOT, ISRAEL—March 4, 2019—Only a few vaccines – for example, polio and rotavirus – can be given orally. Most must be delivered by injection. Weizmann Institute of Science researchers suggest this may be, in part, because the “training program” of the immune cells in the gut takes place under harsh conditions. Using a novel imaging method that captures all of the immune cells’ niches within a single organ, Dr. Ziv Shulman and research student Adi Biram investigated the training process for the gut-based cells involved in long-term immunity. Their findings, published in Nature Immunology, provide new insights that may, in the future, lead to the design of more effective oral vaccines.
Jul 23, 2019...
Image by Tashatuvango via Shutterstock.com
A trailblazing study by Israeli researchers suggests that intestinal microbes may have a direct effect on the course of amyotrophic lateral sclerosis (ALS), the incurable, fatal neurodegenerative disease also known as Lou Gehrig’s disease that affected physicist Stephen Hawking.
Published today in Nature, the study by researchers at the Weizmann Institute of Science revealed that the progression of an ALS-like disease in lab mice was slowed after the mice received certain strains of gut microbes or substances known to be secreted by these microbes.
Jul 22, 2019...
When immune cells (macrophage, blue) meet bacteria (red), the first day or two is critical for the eventual outcome
REHOVOT, ISRAEL—July 22, 2019—First impressions are important – they can set the stage for the entire course of a relationship. The same is true for the impressions the cells of our immune system form when they first meet a new bacterium. Using this insight, Weizmann Institute of Science researchers have developed an algorithm that may predict the onset of diseases such as tuberculosis. The findings of this research were published in Nature Communications.
Jan 21, 2020...
Non-communicable diseases including heart disease, cancer and lung disease are now the most common causes of death, accounting for 70 percent of deaths worldwide. These diseases are considered “non-communicable” because they are thought to be caused by a combination of genetic, lifestyle and environmental factors and can't be transmitted between people.
A new research paper in Science by a team of fellows in CIFAR's Humans and the Microbiome program throws this long-held belief into question by providing evidence that many diseases may be transmissible between people through microbes (including bacteria, fungi, and viruses) that live in and on our bodies.
Nov 18, 2019...
The idea of ‘gut health’ barely existed a few years ago, but now, people in the UK spend around £750 million every year on probiotic products — ‘beneficial’ bacteria which is supposed to boost our health.
People take probiotics believing they increase levels of beneficial bacteria and will boost their immune system, digestion, mental health and more.
But last week, an expert warned that fermented foods such as sauerkraut — often consumed because of their probiotic effect — may trigger bloating, headaches and allergies.
https://www.weizmann-usa.org/news-media/news-releases/same-microbe-different-effect/
Mar 27, 2019...
Seemingly identical bacteria may harbor genetic differences that affect the host-microbiome relationship
REHOVOT, ISRAEL—March 27, 2019—Our gut microbiome – the complement of bacteria we carry around in our intestines – has been linked to everything from obesity and diabetes to heart disease and even neurological disorders and cancer. In recent years, researchers have been sorting through the multiple bacterial species that populate the microbiome, asking which of them can be implicated in specific disorders. But a paper recently published in Nature addressed a new question: “What if the same microbe is different in different people?”
https://www.weizmann-usa.org/news-media/in-the-news/the-secret-social-lives-of-viruses/
Jun 18, 2019...
Illustration by Karol Banach
Geneticist Rotem Sorek could see that his bacteria were sick — so far, so good. He had deliberately infected them with a virus to test whether each ailing microbe soldiered on alone or communicated with its allies to fight the attack.
But when he and his team at the Weizmann Institute of Science in Rehovot, Israel, looked into the contents of their flasks, they saw something completely unexpected: the bacteria were silent, and it was the viruses that were chattering away, passing notes to each other in a molecular language only they could understand. They were deciding together when to lie low in the host cell and when to replicate and burst out, in search of new victims.
Oct 24, 2019... Evogene Ltd. (Nasdaq: EVGN; TASE:EVGN) biopharmaceutical unit Biomica, which is developing innovative microbiome-based therapeutics, has announced a collaboration with the Weizmann Institute of Science to develop a selective treatment against antibiotic resistant strains of Staphylococcus aureus infection. This microbiome focused approach aims to target a specific microbe while maintaining the microbiome of the patients’ gut. The company has in-licensed Prof. Ada Yonath’s, Nobel Prize laureate, work and discoveries in high-resolution crystal structure of the large ribosomal subunit of the pathogenic Staphylococcus aureus. The crystal structure originates from pathogenic species, allowing a high degree of specificity, and together with Biomica’s unique computational technology, will enable the design and development of new types of selective, narrow spectrum antibiotics agents. Prof. Yonath’s group will scientifically support Biomica in the development of the technology.
©2022 American Committee for the Weizmann Institute of Science
